-

Bayer Appoints Ben Kampelman as Vice President of Communications for Crop Science North America

ST. LOUIS--(BUSINESS WIRE)--Bayer today announced that Ben Kampelman, formerly Director, Strategic Communications for Crop Science North America, has been appointed to the role of Vice President of Communications, Crop Science North America.

In this role, Kampelman will lead all internal and external corporate communications activities, including corporate reputation, media relations, employee communications and digital communications for the Crop Science division in North America.

“From his many years with the company, Ben brings a vast knowledge of our business but combines that experience with an optimism for the future of agriculture and how Bayer can realize its vision of Health for All, Hunger for None,” said Beth Roden, Senior Vice President and Head of Communications for Bayer U.S. “His expertise will be key in continuing to drive communications and support the reputation of our largest division in our largest region.”

Kampelman joined the Bayer U.S. Communications Team from its Global Investor Relations team, where he was responsible for investor communication and presentations, including sell-side conference participation, special investor events, quarterly earnings reporting and issues management with a focus on the Crop Science division. He started his career at Monsanto more than 20 years ago, joining the company as a Communications Associate and has served a variety of roles with increasing responsibilities across communications, operations and marketing. Kampelman has supported internal communications for the U.S. sales division; led coordination of the Technology organization’s communication; and served as a marketing manager where he developed the brand messaging plan for one of the company’s key herbicide tolerance platforms.

“I am very excited to take on this new role and become part of the U.S. Communications leadership team and work with my Crop Science communications colleagues around to globe,” Kampelman said. “I’m looking forward to collaborating with colleagues to help drive communications in North America.”

Kampelman assumed his new responsibilities in November 2022. He holds a bachelor’s degree in Journalism from the University of Missouri-Columbia.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. R&D expenses before special items amounted to 5.3 billion euros. For more information, go to www.bayer.com.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Social Media Channels

- Facebook: BayerUnitedStates
- Twitter: BayerUS
- Instagram: BayerUS
- YouTube: BayerUS

Bayer® and the Bayer Cross® are registered trademarks of Bayer.

Contacts

Media:
Nicole Hayes
Director, U.S. External Communications
Nicole.Hayes@Bayer.com
(201) 421-5268

Bayer


Release Versions

Contacts

Media:
Nicole Hayes
Director, U.S. External Communications
Nicole.Hayes@Bayer.com
(201) 421-5268

More News From Bayer

Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigation

LEVERKUSEN--(BUSINESS WIRE)--The U.S. Supreme Court today announced that it will review the Durnell Roundup™ case. Monsanto petitioned the court to hear Durnell in April 2025 and address the split in authority among federal circuit courts on the application of federal preemption, a cross-cutting issue in the Roundup™ litigation. The company expects a decision on the merits during the Court’s 2026 session, which ends in June. “The Supreme Court decision to take the case is good news for U.S. far...

Bayer Accelerates Pharma Growth on High-Value Portfolio

SAN FRANCISCO--(BUSINESS WIRE)--On the occasion of the 44th J.P. Morgan Healthcare Conference in San Francisco, Bayer AG today unveiled the strategic focus for its Pharmaceuticals Division in 2026. Capitalizing on new launch momentum, the company will drive significant global regulatory expansions and market penetration across its pharmaceutical portfolio. High-value commercial products and an accelerating modality-rich pipeline across oncology, cardiology, neurology, and immunology have firmly...

Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Menopause

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it has partnered with actress and menopause advocate Gabrielle Union-Wade on the ‘Life Doesn’t Stop for a Hot Flash’ campaign, which speaks to women with moderate to severe hot flashes due to menopause. The campaign encourages women to have an open and honest conversation with their healthcare provider about their hot flash experiences and learn about treatment options, including Lynkuet® (elinzanetant) 60mg capsules, a hormone-free prescri...
Back to Newsroom